Parenteral Drug Product Manufacturing

Parenteral Drug Product Manufacturing
Product Description

Parenteral Formats: vials, accessorized prefilled syringes, autoinjectors, pen injectors, and cartridges 

Formulation: parenteral aseptic liquid, including adjuvant, suspension, and other complex presentations 

Finishing: 100% visual inspection, device assembly, packaging, serialization, and aggregation 

Modalities: mAbs, proteins, plasma??-derived products, mRNA, peptides, oligonucleotides, and both small and large molecules 

Stage coverage: clinical and commercial, GMP and non-GMP 

Network: North American footprint, with integrated drug substance and drug product capabilities 

Storage: ambient and 2–8°C cold-chain, serialized for distribution-ready supply 

Read more Show less

Resilience

  • Country/Region:
    United States
  • Founded:
    2020
  • On CPHI since:
    2023
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Analytical Services
Biopharmaceutical
Contract Manufacturer
Intermediates Manufacturer
Packaging & drug delivery
Pharmaceutical Company (innovator finished products)
Supply Chain
Technology
View company profile
Categories
more categories Show less
Specifications
  • Details
    Resilience provides clinical and commercial parenteral drug product manufacturing within an integrated North American network: aseptic formulation, sterile fill/finish, and device assembly across autoinjectors, pens, syringes, and cartridges. Programs move from formulation through fill and inspection into serialized, distribution-ready finished goods in the same network. And with integrated drug substance capabilities, programs can move from drug substance to market-ready product with fewer handoffs along the way.  
More specifications Fewer specifications

Resilience

  • Country/Region:
    United States
  • Founded:
    2020
  • On CPHI since:
    2023
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Analytical Services
Biopharmaceutical
Contract Manufacturer
Intermediates Manufacturer
Packaging & drug delivery
Pharmaceutical Company (innovator finished products)
Supply Chain
Technology
View company profile

More Products from Resilience (4)

  • Large Molecule Biologics Development

    Product Large Molecule Biologics Development

    Modalities: monoclonal antibodies, Fab fragments, Fc fusion proteins, recombinant proteins, and ADC intermediates 

    Scale: pilot-scale single-use bioreactors from 3 L to 500 L for process development and characterization 

    Stage coverage: preclinical and early phase through la...
  • Device Assembly, Packaging & Logistics

    Product Device Assembly, Packaging & Logistics

    Device platforms: autoinjector, accessorized prefilled syringe, and cartridge assembly, supporting APFS, Ypsomed, and SHL platforms, plus additional device and proprietary platforms [TK: confirm current platform list] 

    Packaging: labeling, serialization, and aggregation across bulk, multi-u...
  • Drug Substance Manufacturing

    Product Drug Substance Manufacturing

    Modalities: monoclonal antibodies, recombinant proteins (including complex and non-cytotoxic conjugated), fusion proteins, enzymes, bispecifics, and plasma proteins 

    Scale: single-use bioreactors 3L to 500L (development) and 50L to 2,000L (manufacturing) 

    Stage coverage: pre...
  • Sterile Fill/Finish

    Product Sterile Fill/Finish

    Formats: vials, pre-filled syringes, and cartridges 

    Fill technology: isolator- and RABS-based automated and semi-automated lines 

    Sites: Toronto and Cincinnati, both commercially licensed 

    Stage coverage: clinical and commercial, GMP and non-GMP 
    ...